Scandinavian ChemoTech AB Series B

Research Scandinavian ChemoTech AB Series B (CMOTEC-B) on Bullrun: market cap SEK 98.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCMOTEC-B
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 98.83M
• Financial periodQ1 2026
• RevenueSEK 2.80M
• Net income-SEK 1.57M
• Free cash flow-SEK 1.14M
• Gross margin86.8%

Valuation Snapshot

latest market cap is SEK 98.83M.

About Scandinavian ChemoTech AB Series B

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

Frequently asked questions

What is Scandinavian ChemoTech AB Series B's market cap?

Scandinavian ChemoTech AB Series B's market capitalization is SEK 98.83M.

What does Scandinavian ChemoTech AB Series B do?

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally.